cancer life science


Access to cancer medicines in Australia

Deloitte Access Economics

Cancer is an area of high clinical need in Australia.

Download the report

Access to cancer medicines in Australia

Past investment in cancer care has resulted in the country being a world leader in cancer control, but disease incidence is projected to grow significantly over the next 20 years.

In this report for the Medicines Australia Oncology Industry Taskforce, Deloitte Access Economics has assessed the disease patterns and economics of cancer in Australia and internationally, and canvassed the opinions of various stakeholders on issues pertaining to patient access to cancer medicines.

More topics


Deloitte Access Economics

Deloitte Access Economics offers a full suite of macro and microeconomic advisory services.


Life at Deloitte

People make Deloitte one of the best places to work. What’s great about the people? That’s an easy answer. They are exceptional. Each person is unique and valued for that, among the best and brightest in the business, and takes pride in his or her achievements and the success of others.